Scarica l'app Stockscreener
0.206
34.08%
-0.1065
Pre-mercato:
.22
0.014
+6.80%
Precedente Chiudi:
$0.3125
Aprire:
$0.335
Volume 24 ore:
6.69M
Relative Volume:
0.64
Capitalizzazione di mercato:
$10.20M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-52.42%
1M Prestazione:
-64.19%
6M Prestazione:
-64.64%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$0.2012
$0.335
Intervallo di 1 settimana:
$0.2012
$0.4498
Portata 52W:
$0.2012
$2.10
Aspire Biopharma Holdings Inc Stock (ASBP) Company Profile
Nome
Aspire Biopharma Holdings Inc
Settore
Industria
Telefono
561-704-8527
Indirizzo
194 CANDELARO DRIVE, #233, HUMACAO
Confronta ASBP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ASBP
Aspire Biopharma Holdings Inc
|
0.206 | 15.48M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Aspire Biopharma Holdings Inc Borsa (ASBP) Ultime notizie
Is There Hidden Value in Modern Engineering and Projects Limiteds Business ModelQuarterly Earnings Review & Double Digit Trading Ideas - earlytimes.in
What drives Aspire Biopharma Holdings Inc Equity Warrant stock priceCandlestick Trading Patterns & Best Stocks For Explosive Growth - earlytimes.in
What analysts say about Aspire Biopharma Holdings Inc stockShort-Term Trading Alerts & Free Powerful Profit Generation - earlytimes.in
What analysts say about Aspire Biopharma Holdings Inc Equity Warrant stockResistance Zone Identification & Register for the Next Free Workshop - earlytimes.in
How Star Equity Holdings Inc. (FDV0) stock trades after earningsIPO Watch & Reliable Breakout Forecasts - newser.com
Aspire Biopharma Holdings Inc Stock Analysis and ForecastPrice-to-Earnings Ratio Insights & Minimal Investment Capital - earlytimes.in
Aspire Biopharma Holdings Inc Equity Warrant Stock Analysis and Forecast - earlytimes.in
Aspire Biopharma completes $1 million funding tranche and changes auditor - Investing.com
Aspire Biopharma Announces Breakthrough Final Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack) - Detroit Free Press
Aspire Biopharma Holdings, Inc. Announces CEO Transition - Foster's Daily Democrat
Aspire Biopharma files to sell 147.18M shares of common stock for holders - MSN
Aspire Biopharma Enlists Fitness Influencers To Promote Pre-Workout Product - Net Influencer
Aspire Biopharma secures initial order for preworkout supplement, part of agreement with SupraNatural - MSN
Aspire Biopharma Holdings Inc (NASDAQ: ASBP) 8.11% Incline Turns Away Investor Interest In Company’s Stock - stocksregister.com
Aspire Biopharma Engages Well-Known Athletes and Influencers to Accelerate Consumer Awareness and Sales of its BUZZ BOMB(TM) Sublingual Caffeine Pre-Workout Product - ACCESS Newswire
Aspire Biopharma Engages Well-Known Athletes and Influencers to Accelerate Consumer Awareness and Sales of its BUZZ BOMB(TM) Sublingual Caffeine Pre-Workout Product | FinancialContent - FinancialContent
Aspire Biopharma Announces Initial Production Order of Two Million Servings (100,000 20-packs) of BUZZ BOMB(TM) Pre-Workout Supplement - ACCESS Newswire
2 Million Unit Production Order: Aspire Biopharma Scales BUZZ BOMB Pre-Workout in $27.9B Market - Stock Titan
Aspire Biopharma Holdings, Inc. Unveils E-commerce Platform, Launches with its BUZZ BOMB Pre-Workout Supplement - Fall River Herald News
Can volume confirm reversal in NCR Voyix CorporationEarnings Overview Report & Safe Investment Capital Preservation Plans - newser.com
Aspire Biopharma Holdings, Inc., Announces Last Patient Dosed in Phase 1 Clinical Trial of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation - The Florida Times-Union
Aspire Biopharma Holdings, Inc. to Launch its BUZZ BOMB Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World - The Florida Times-Union
Aspire Biopharma Reports Final Results in Sublingual Aspirin Trial for Heart Attack Treatment; Shares Fall Pre Bell - MarketScreener
2-Minute Response Time: Aspire's New Sublingual Aspirin Could Revolutionize Heart Attack Treatment - Stock Titan
PRN_FinancialWrapper - FinancialContent
How to track smart money flows in Banc of California Inc.Weekly Profit Report & Daily Volume Surge Trade Alerts - Newser
Risk vs reward if holding onto Theravance Biopharma Inc.Weekly Investment Recap & Fast Moving Market Watchlists - Newser
How to track smart money flows in aTyr Pharma Inc.2025 Price Targets & Free Real-Time Volume Trigger Notifications - Newser
ExlService Holdings Inc. stock chart pattern explainedTrade Exit Summary & Free Safe Entry Trade Signal Reports - Newser
Combining price and volume data for Shell plc Depositary ReceiptEarnings Risk Summary & Technical Buy Zone Confirmation - Newser
Aspire Biopharma Secures $9.7M Through Securities Agreement - MSN
How to track smart money flows in TTEC Holdings Inc.2025 Fundamental Recap & AI Based Buy and Sell Signals - Newser
Historical volatility pattern of Zoomcar Holdings Inc. visualizedJuly 2025 Trends & Precise Swing Trade Entry Alerts - Newser
What earnings revisions data tells us about Newton Golf Company Inc.July 2025 News Drivers & Real-Time Buy Signal Alerts - Newser
Risk vs reward if holding onto Edesa Biotech Inc.2025 Market Trends & Risk Adjusted Swing Trade Ideas - Newser
What MACD and RSI say about CHSNWeekly Trend Summary & Advanced Swing Trade Entry Alerts - Newser
Aspire Biopharma enters $9.7 million note purchase agreement with investors By Investing.com - Investing.com Nigeria
Aspire Biopharma's Debt Refinancing: A Strategic Play for Biotech Capital Structure Optimization and Operational Flexibility - AInvest
Aspire Biopharma Holdings, Inc. Building a Base Near Support2025 Retail Activity & Weekly Setup with High ROI Potential - thegnnews.com
Promising Penny Stocks To Consider – August 18th - Defense World
Aspire Biopharma Plummets 22.7%: E-Commerce Launch Volatility and Technical Divergence Spark Turbulence - AInvest
Aspire Biopharma Announces Positive Top-Line Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack) - BioSpace
Penny Stocks on the Move: Today’s Top Gainers and Biggest Decliners - AInvest
Aspire Shares Are Trading Higher Monday: What's Going On?Aspire Biopharma Hldgs (NASDAQ:ASBP) - Benzinga
Crude Oil Moves Higher; US Homebuilder Sentiment Declines In August - Benzinga
Aspire Biopharma Holdings shares surge 67.69% intraday after positive clinical trial results for sublingual aspirin product. - AInvest
US Stocks Mixed; Riskified Shares Dip After Q2 Results - Benzinga
Breakthrough Heart Attack Treatment: Sublingual Aspirin Shows Superior Results in Aspire Biopharma Trial - Stock Titan
Aspire Biopharma Holdings Inc Azioni (ASBP) Dati Finanziari
Non sono disponibili dati finanziari per Aspire Biopharma Holdings Inc (ASBP). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
2.36%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):